WASHINGTON, Oct. 24 /PRNewswire/ -- ICx Technologies, a developer of advanced technology solutions for homeland and military security, announced today that it has entered into a new development and license option agreement with Siemens Medical Solutions Diagnostics to develop diagnostic sensors. The goal is to generate new diagnostic tests based on proprietary enzyme-polymer chemistries developed by ICx, and know-how for use in Siemens' blood gas analyzer systems.
Under the terms of the agreement, ICx will receive development milestone payments as well as upon exercise of the option royalties on worldwide net sales from any successfully developed products. Neither the financial terms nor the diagnostic target were disclosed.
About ICx Technologies(TM)
ICx develops advanced technologies for effective security solutions. ICx sensors detect and identify chemical, biological, radiological, nuclear and explosive (CBRNE) materials. ICx surveillance products discern people and objects invisible to human senses and conventional cameras. ICx software and systems connect, command and control these security devices, while its intelligence and special-operations experts provide the unique insight that drives the company's innovation. ICx has manufacturing and research facilities in the United States , Canada and Europe . http://www.icxt.com
About Siemens Medical Solutions Diagnostics
Siemens Medical Solutions Diagnostics offers a broad portfolio of performance-driven diagnostic solutions that assist in the diagnosis, monitoring and management of disease. Products and services bring together the right balance of science, technology, and practicality across the healthcare continuum to empower medical professionals with the vital information they need to deliver better, more personalized healthcare to patients around the globe. Visit http://www.siemens.com/diagnostics.
All trademarks, registered trademarks and service marks are the property of their respective owners.
SOURCE ICx Technologies